tiprankstipranks
Trending News
More News >
Church & Dwight Company (CHD)
:CHD
Advertisement

Church & Dwight (CHD) AI Stock Analysis

Compare
933 Followers

Top Page

CHD

Church & Dwight

(NYSE:CHD)

Rating:70Outperform
Price Target:
$104.00
â–²(12.58% Upside)
Church & Dwight's overall stock score reflects a stable financial position and strategic initiatives like the Touchland acquisition. However, high valuation and challenges in certain business segments weigh on the score.
Positive Factors
Acquisitions
The acquisition of Touchland aligns well with Church & Dwight's criteria as it is the fastest growing brand in hand sanitizer, asset light, and gross margin accretive.
Earnings
CHD reported better than expected Q2 results, with organic sales up 0.1%, exceeding expectations, driven by strong brand share growth, innovation, and positive category consumption trends.
Market Share
CHD's market share prospects are improving, highlighting its historical strong management track record and category recovery.
Negative Factors
Guidance
Management remained cautious and guided for organic growth below consensus.
Market Valuation
The premium valuation of 25.4 times 2026 EPS is seen as already reflecting the benefit of the doubt, considering muted year-over-year growth.
Retail and Consumer Trends
Volumes were negatively impacted by retailer destocking, which is expected to remain a headwind given below-historical category growth rates.

Church & Dwight (CHD) vs. SPDR S&P 500 ETF (SPY)

Church & Dwight Business Overview & Revenue Model

Company DescriptionChurch & Dwight Co., Inc. is an American consumer goods company known for its diverse portfolio of products primarily in the household and personal care sectors. Founded in 1846, the company operates in various categories, including laundry detergent, personal care, and health care. Some of its most recognized brands include Arm & Hammer, Trojan, and OxiClean. The company is headquartered in Ewing, New Jersey, and serves a global market with a focus on innovation and sustainability in its product offerings.
How the Company Makes MoneyChurch & Dwight generates revenue through the sale of consumer products across several key categories, including laundry and cleaning products, personal care items, and health care products. The company employs a multi-channel distribution strategy that includes retail, e-commerce, and direct-to-consumer sales. Key revenue streams come from established brands like Arm & Hammer and Trojan, which are leaders in their respective markets. Additionally, Church & Dwight invests in marketing and product innovation to drive sales growth. Strategic partnerships with retailers and distributors also enhance their market presence and accessibility, contributing significantly to revenue. Seasonal promotions, product launches, and expanding international markets further bolster the company's financial performance.

Church & Dwight Key Performance Indicators (KPIs)

Any
Any
Consumer Domestic Revenue
Consumer Domestic Revenue
Focuses on revenue generated from domestic consumer sales, providing insight into the company's performance in its home market and its ability to capture and retain local market share.
Chart InsightsChurch & Dwight's Consumer Domestic Revenue shows steady growth in Household Products, but Personal Care Products are facing challenges. Despite recent declines, the earnings call highlighted strategic moves like the acquisition of Touchland and strong brand performances, such as ARM & HAMMER and THERABREATH, which could bolster future growth. However, pressures from tariffs, inflation, and product recalls are impacting margins. The company is focusing on innovation and strategic brand management to navigate these challenges, aiming for modest organic sales growth of 0% to 2% for the year.
Data provided by:Main Street Data

Church & Dwight Earnings Call Summary

Earnings Call Date:Aug 01, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Oct 24, 2025
Earnings Call Sentiment Neutral
Church & Dwight's earnings call presented a mixed picture. The acquisition of Touchland and growth in international markets and online sales were significant positives. However, challenges in the vitamin business, gross margin declines, and issues in the U.S. consumer business and BATISTE brand consumption created areas of concern.
Q2-2025 Updates
Positive Updates
Touchland Acquisition Success
Church & Dwight closed the acquisition of Touchland, which is the fastest-growing brand in the hand sanitizer category in the U.S., and is the #2 hand sanitizer in the category. Touchland experienced strong growth in Q2, outpacing the category and gaining share.
International Segment Growth
International sales grew 5.3% in the quarter, with organic sales increasing by 4.8% due to a combination of higher volume, price, and mix. Growth was led by HERO, THERABREATH, and FEMFRESH.
Online Sales Expansion
Online sales as a percentage of global sales reached 23%, reflecting a continuing trend towards e-commerce.
THERABREATH and HERO Brand Performance
THERABREATH consumption grew 22.5%, maintaining its position as the #2 mouthwash with a 21% share. HERO outpaced the acne category with consumption growth of 11.4%, remaining the #1 brand in acne care with a 22% share.
Negative Updates
Gross Margin Decline
Adjusted gross margin decreased by 40 basis points from a year ago, affected by inflation, tariffs, and a product recall.
Vitamin Business Challenges
The gummy vitamin business was a drag on organic growth, with consumption down around 25% due to TDP declines, despite the category growing almost 4%.
U.S. Consumer Business Sales Decline
Organic sales for the U.S. consumer business declined 1%, with volume growth offset by negative price mix.
BATISTE Consumption Decline
BATISTE experienced a nearly 7% decline in consumption due to competitive price increases, economic pressure driving trade down, and supply issues.
Company Guidance
During the Church & Dwight Second Quarter 2025 Earnings Conference Call, the company provided guidance and insights into its financial performance and strategic initiatives. Organic sales grew by 0.1%, surpassing the initial outlook of minus 2% to flat. The adjusted gross margin decreased by 40 basis points, which also exceeded expectations. Adjusted EPS reached $0.94, exceeding the previous outlook of $0.85. The company remains confident in achieving its full-year organic growth target of 0% to 2%. Church & Dwight highlighted the acquisition of Touchland, which contributed positively to sales and market share in the hand sanitizer category. The company is undergoing a strategic review of its vitamin business, considering options such as potential joint ventures or divestitures due to mixed results in revitalization efforts. Despite challenges, the company is optimistic about its brand performance, new product launches, and continued share gains across key categories. The international segment reported a 5.3% sales growth, driven by higher volume, price, and mix. Looking ahead, Church & Dwight maintains a full-year adjusted EPS growth expectation of 0% to 2%, factoring in the Touchland acquisition and strategic exits of certain businesses.

Church & Dwight Financial Statement Overview

Summary
Church & Dwight shows a solid financial foundation with strong cash flow management and a stable balance sheet. However, the decline in revenue growth and pressure on margins highlight areas for improvement.
Income Statement
70
Positive
Church & Dwight's income statement shows a mixed performance. The TTM data indicates a decline in revenue growth rate by 8.1%, which is concerning. However, the company maintains a healthy gross profit margin of 44.47% and a net profit margin of 8.66%. The EBIT and EBITDA margins have decreased compared to previous years, suggesting some pressure on operational efficiency.
Balance Sheet
75
Positive
The balance sheet reflects a stable financial position with a debt-to-equity ratio of 0.50, indicating moderate leverage. The return on equity (ROE) stands at 12.01%, showing a reasonable return for shareholders. The equity ratio is approximately 50%, suggesting a balanced capital structure with a good proportion of equity financing.
Cash Flow
80
Positive
Cash flow analysis reveals strong free cash flow growth of 18.3% in the TTM period. The operating cash flow to net income ratio is 0.89, indicating efficient cash generation relative to net income. The free cash flow to net income ratio is 0.87, reflecting robust cash flow management.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue6.07B6.11B5.87B5.38B5.19B4.90B
Gross Profit2.70B2.79B2.59B2.25B2.26B2.21B
EBITDA1.02B1.09B1.30B831.90M1.31B1.22B
Net Income525.20M585.30M755.60M413.90M827.50M785.90M
Balance Sheet
Total Assets8.79B8.88B8.57B8.35B8.00B7.41B
Cash, Cash Equivalents and Short-Term Investments923.20M964.10M344.50M270.30M240.60M183.10M
Total Debt2.21B2.20B2.41B2.67B2.56B2.16B
Total Liabilities4.39B4.52B4.71B4.86B4.76B4.39B
Stockholders Equity4.39B4.36B3.86B3.49B3.23B3.02B
Cash Flow
Free Cash Flow930.60M976.40M807.10M706.40M875.00M891.40M
Operating Cash Flow1.07B1.16B1.03B885.20M993.80M990.30M
Investing Cash Flow-131.40M-183.30M-234.30M-728.60M-682.00M-608.10M
Financing Cash Flow-512.80M-343.40M-725.60M-120.90M-252.10M-360.10M

Church & Dwight Technical Analysis

Technical Analysis Sentiment
Negative
Last Price92.38
Price Trends
50DMA
95.05
Negative
100DMA
96.51
Negative
200DMA
101.51
Negative
Market Momentum
MACD
-0.47
Negative
RSI
46.10
Neutral
STOCH
21.63
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CHD, the sentiment is Negative. The current price of 92.38 is below the 20-day moving average (MA) of 92.79, below the 50-day MA of 95.05, and below the 200-day MA of 101.51, indicating a neutral trend. The MACD of -0.47 indicates Negative momentum. The RSI at 46.10 is Neutral, neither overbought nor oversold. The STOCH value of 21.63 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CHD.

Church & Dwight Risk Analysis

Church & Dwight disclosed 34 risk factors in its most recent earnings report. Church & Dwight reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Church & Dwight Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
$365.34B23.9931.23%2.63%0.29%7.85%
73
Outperform
$151.72B25.3328.36%3.18%-0.30%-14.60%
71
Outperform
$14.39B18.32249.61%4.12%0.16%191.17%
70
Outperform
$22.50B43.7512.07%1.26%1.13%-34.78%
63
Neutral
$68.00B23.63705.21%2.42%0.05%3.55%
63
Neutral
$20.46B14.47-3.60%3.13%2.63%-6.18%
60
Neutral
$43.07B18.02196.26%3.81%-6.89%7.52%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CHD
Church & Dwight
93.03
-6.56
-6.59%
CLX
Clorox
118.97
-33.01
-21.72%
CL
Colgate-Palmolive
84.45
-19.04
-18.40%
KMB
Kimberly Clark
130.21
-8.03
-5.81%
PG
Procter & Gamble
156.96
-8.88
-5.35%
UL
Unilever
62.52
-0.43
-0.68%

Church & Dwight Corporate Events

Private Placements and FinancingBusiness Operations and Strategy
Church & Dwight Enters New $2 Billion Credit Agreement
Positive
Jul 18, 2025

On July 17, 2025, Church & Dwight Co., Inc. entered into a new Credit Agreement, replacing its previous $1.5 billion unsecured revolving credit facility from June 16, 2022. The new agreement increases the aggregate commitments to $2.0 billion, with an option to extend to $2.75 billion, and includes various interest rate options and covenants. This strategic financial move aims to enhance the company’s financial flexibility and support its operational needs, potentially impacting its market positioning and stakeholder interests.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 22, 2025